{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:29:59Z","timestamp":1792092599561,"version":"4.4.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Low-density lipoprotein cholesterol (LDL-C) is an established marker for cardiovascular disease (CVD) and a therapeutic target. Oxidized LDL (oxLDL) is known to be associated with excessive inflammation and abnormal lipoprotein metabolism. Chronic inflammatory diseases confer an elevated risk of premature atherosclerosis and adverse cardiovascular events. Whether oxLDL may serve as a potential biomarker for CVD stratification in populations with chronic inflammatory conditions remains understudied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To perform a systematic review and meta-analysis evaluating the relationship between oxLDL and CVD (defined by incident CVD events, carotid intima-media thickness, presence of coronary plaque) in patients with chronic inflammatory diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic literature search was performed using studies published between 2000 and 2022 from PubMed, Cochrane Library, Embase (Elsevier), CINHAL (EBSCOhost), Scopus (Elsevier), and Web of Science: Core Collection (Clarivate Analytics) databases on the relationship between oxLDL and cardiovascular risk on inflamed population. The pooled effect size was combined using the random effect model and publication bias was assessed if <jats:italic>P<\/jats:italic> &amp;lt; 0.05 for the Egger or Begg test along with the funnel plot test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of three observational studies with 1,060 participants were ultimately included in the final meta-analysis. The results demonstrated that oxLDL is significantly increased in participants with CVD in the setting of chronic inflammatory conditions. This meta-analysis suggests that oxLDL may be a useful biomarker in risk stratifying cardiovascular disease in chronically inflamed patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.1023651","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:50:35Z","timestamp":1673848235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Christin G.","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Florida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Parel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal N.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1056\/NEJMe1709904","article-title":"Targeting inflammation in coronary artery disease","volume":"377","author":"Harrington","year":"2017","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature."},{"key":"B4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jacc.2014.11.041","article-title":"The myth of the \u201cvulnerable plaque\u201d: transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment","volume":"65","author":"Arbab-Zadeh","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1161\/ATVBAHA.116.307993","article-title":"Atherosclerotic plaque rupture: identifying the straw that breaks the camel's back","volume":"36","author":"Chen","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.2021.5469","article-title":"The leading causes of death in the Us for 2020","volume":"325","author":"Ahmad","year":"2021","journal-title":"Jama."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-015-0255-y","article-title":"Atherosclerotic cardiovascular disease: a review of initiators and protective factors","volume":"24","author":"Ellulu","year":"2016","journal-title":"Inflammopharmacology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions","volume":"36","author":"Mason","year":"2015","journal-title":"Eur Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11904-016-0321-0","article-title":"Lipid abnormalities and inflammation in HIV inflection","volume":"13","author":"Funderburg","year":"2016","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.tcm.2019.11.001","article-title":"Chronic inflammation, cardiometabolic diseases and effects of treatment: psoriasis as a human model","volume":"30","author":"Aksentijevich","year":"2020","journal-title":"Trends Cardiovasc Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"H867","DOI":"10.1152\/ajpheart.00774.2016","article-title":"Psoriasis as a human model of disease to study inflammatory atherogenesis","volume":"312","author":"Harrington","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1002\/art.24677","article-title":"Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus","volume":"60","author":"McMahon","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejr.2016.03.003","article-title":"Atherosclerosis biomarkers in female systemic lupus erythematosus patients with and without cardiovascular diseases","volume":"39","author":"Khairy","year":"2017","journal-title":"Egypt Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 Aha\/Acc\/Aacvpr\/Aapa\/Abc\/Acpm\/Ada\/Ags\/Apha\/Aspc\/Nla\/Pcna guideline on the management of blood cholesterol: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/acr.21631","article-title":"Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?","volume":"64","author":"Finckh","year":"2012","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.amjcard.2004.03.023","article-title":"Framingham risk score and prediction of lifetime risk for coronary heart disease","volume":"94","author":"Lloyd-Jones","year":"2004","journal-title":"Am J Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"R186","DOI":"10.1186\/ar2098","article-title":"Utility of the framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis","volume":"8","author":"Chung","year":"2006","journal-title":"Arthritis Res Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/1346-8138.12267","article-title":"Framingham risk score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease","volume":"40","author":"Torres","year":"2013","journal-title":"J Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/heartjnl-2020-318760","article-title":"Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges","volume":"107","author":"Packard","year":"2021","journal-title":"Heart."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(10)60713-1","article-title":"Hdl cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the jupiter trial","volume":"376","author":"Ridker","year":"2010","journal-title":"Lancet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/01.mol.0000236367.42755.c1","article-title":"Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease","volume":"17","author":"Packard","year":"2006","journal-title":"Curr Opin Lipidol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"Test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3109\/10408363.2014.992063","article-title":"Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases","volume":"52","author":"Trpkovic","year":"2015","journal-title":"Crit Rev Clin Lab Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2016.05.013","article-title":"Physiology and pathophysiology of oxldl uptake by vascular wall cells in atherosclerosis","volume":"84","author":"Di Pietro","year":"2016","journal-title":"Vascul Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2012.08.030","article-title":"Ldl oxidative modification and carotid atherosclerosis: results of a multicenter study","volume":"225","author":"Nyyss\u00f6nen","year":"2012","journal-title":"Atherosclerosis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.biocel.2007.03.012","article-title":"Cd36: Implications in cardiovascular disease","volume":"39","author":"Febbraio","year":"2007","journal-title":"Int J Biochem Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/ATVBAHA.120.315421","article-title":"Role of Lox-1 (lectin-like oxidized low-density lipoprotein receptor 1) as a cardiovascular risk predictor: mechanistic insight and potential clinical use","volume":"41","author":"Barreto","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2143\/AC.59.5.2005219","article-title":"Oxidized Ldl and coronary heart disease","volume":"59","author":"Holvoet","year":"2004","journal-title":"Acta Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1161\/01.ATV.21.5.844","article-title":"Circulating oxidized ldl is a useful marker for identifying patients with coronary artery disease","volume":"21","author":"Holvoet","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijcard.2018.03.077","article-title":"Ldl-oxidation, serum uric acid, kidney function and pulse-wave velocity: data from the brisighella heart study cohort","volume":"261","author":"Cicero","year":"2018","journal-title":"Int J Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.118.313608","article-title":"Association between oxidation-modified lipoproteins and coronary plaque in psoriasis","volume":"123","author":"Sorokin","year":"2018","journal-title":"Circ Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.104.529297","article-title":"Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population","volume":"112","author":"Meisinger","year":"2005","journal-title":"Circulation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"Prisma 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/9781119558378","author":"Borenstein","year":"2021","journal-title":"Introduction to Meta-Analysis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1759720X17720366","article-title":"Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations","volume":"9","author":"Ajeganova","year":"2017","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1468-1293.2009.00766.x","article-title":"Nonconcordance between subclinical atherosclerosis and the calculated framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation","volume":"11","author":"Parra","year":"2010","journal-title":"HIV Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e2114923","DOI":"10.1001\/jamanetworkopen.2021.14923","article-title":"Assessment of coronary artery disease with computed tomography angiography and inflammatory and immune activation biomarkers among adults with HIV eligible for primary cardiovascular prevention","volume":"4","author":"Hoffmann","year":"2021","journal-title":"JAMA Netw Open."},{"key":"B42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jamadermatol.2019.3595","article-title":"Association between soluble lectinlike oxidized low-density lipoprotein receptor-1 and coronary artery disease in psoriasis","volume":"156","author":"Dey","year":"2020","journal-title":"JAMA Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.jacc.2013.02.047","article-title":"Oxidation-specific biomarkers and risk of peripheral artery disease","volume":"61","author":"Bertoia","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B44","author":"Wells","year":"2014","journal-title":"The Newcastle-Ottawa Scale (Nos) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1161\/STROKEAHA.106.479030","article-title":"The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection","volume":"38","author":"Coll","year":"2007","journal-title":"Stroke."},{"key":"B46","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1161\/01.ATV.16.7.831","article-title":"The Yin and Yang of oxidation in the development of the fatty streak: a review based on the 1994 george lyman duff memorial lecture","volume":"16","author":"Navab","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/01.CIR.91.1.23","article-title":"Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men","volume":"91","author":"Vaarala","year":"1995","journal-title":"Circulation."},{"key":"B48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0140-6736(86)92258-0","article-title":"Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events","volume":"327","author":"Hamsten","year":"1986","journal-title":"Lancet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/01.ATV.10.3.325","article-title":"Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein","volume":"10","author":"Palinski","year":"1990","journal-title":"Arteriosclerosis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0009-8981(99)00062-5","article-title":"The significance of autoantibodies against oxidatively modified low-density lipoprotein (Ldl) in patients with psoriasis","volume":"284","year":"1999","journal-title":"Clin Chim Acta."},{"key":"B51","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/ar2388","article-title":"Gluten-free vegan diet induces decreased ldl and oxidized ldl levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study","volume":"10","author":"Elkan","year":"2008","journal-title":"Arthritis Res Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.CIR.103.15.1930","article-title":"Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk","volume":"103","author":"Tsimikas","year":"2001","journal-title":"Circulation."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1001\/jama.281.18.1718","article-title":"Malondialdehyde-modified ldl as a marker of acute coronary syndromes","volume":"281","author":"Holvoet","year":"1999","journal-title":"JAMA."},{"key":"B54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0022-2275(20)37634-3","article-title":"Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody","volume":"37","author":"Itabe","year":"1996","journal-title":"J Lipid Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00018-005-5406-7","article-title":"Lipid-lowering drugs","volume":"63","author":"Pahan","year":"2006","journal-title":"Cell Mol Life Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 Acc\/Aha guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the american college of cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation."},{"key":"B57","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1373\/jalm.2016.021006","article-title":"Lipoprotein biomarkers and risk of cardiovascular disease: a laboratory medicine best practices (Lmbp) systematic review","volume":"1","author":"Sandhu","year":"2016","journal-title":"J Appl Lab Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jacc.2008.02.066","article-title":"Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma volume: observations from the reversal (reversal of atherosclerosis with aggressive lipid lowering) study","volume":"52","author":"Choi","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.cjca.2017.07.015","article-title":"Association between circulating oxidized Ldl and atherosclerotic cardiovascular disease: a meta-analysis of observational studies","volume":"33","author":"Gao","year":"2017","journal-title":"Can J Cardiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1161\/01.CIR.0000141728.23033.B5","article-title":"High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein b-100 in patients with acute coronary syndromes in the miracl trial","volume":"110","author":"Tsimikas","year":"2004","journal-title":"Circulation."},{"key":"B61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jjcc.2015.05.017","article-title":"High-dose statin therapy with rosuvastatin reduces small dense ldl and mda-ldl: the standard vs. high-dose therapy with rosuvastatin for lipid lowering (sard) trial","volume":"67","author":"Nishikido","year":"2016","journal-title":"J Cardiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1097\/QAD.0000000000001109","article-title":"Inflammation, immune activation, and cardiovascular disease in HIV","volume":"30","author":"Nou","year":"2016","journal-title":"Aids."},{"key":"B63","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1310\/7381-M1YD-RTV5-4RYT","article-title":"Concentration of circulating oxidized Ldl in HIV-infected patients treated with antiretroviral agents: relation to hiv-related lipodystrophy","volume":"7","author":"Duong","year":"2006","journal-title":"HIV Clin Trials."},{"key":"B64","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/14740338.2019.1620730","article-title":"Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data","volume":"18","author":"Strilchuk","year":"2019","journal-title":"Expert Opin Drug Saf."},{"key":"B65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/14712598.2020.1677604","article-title":"Pcsk9 inhibitors and cardiovascular outcomes","volume":"20","author":"Steffens","year":"2020","journal-title":"Expert Opin Biol Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jacc.2018.04.054","article-title":"The evolving future of pcsk9 inhibitors","volume":"72","author":"Rosenson","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00395-017-0650-1","article-title":"Oxidized low-density lipoprotein (Oxldl) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin\/kexin 9 (Pcsk9)-dependent way","volume":"112","author":"Schl\u00fcter","year":"2017","journal-title":"Basic Res Cardiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3892\/ijmm.2012.1072","article-title":"Pcsk9 sirna suppresses the inflammatory response induced by oxldl through inhibition of Nf-?","volume":"30","author":"Tang","year":"2012","journal-title":"Int J Mol Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tcm.2018.05.010","article-title":"Oxidized Ldl and anti-oxidized Ldl antibodies in atherosclerosis - novel insights and future directions in diagnosis and therapy","volume":"29","author":"Hartley","year":"2019","journal-title":"Trends Cardiovasc Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1161\/01.ATV.15.5.704","article-title":"Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apob-containing serum lipoproteins","volume":"15","author":"Hammer","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/01.ATV.14.4.605","article-title":"Apoe-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum","volume":"14","author":"Palinski","year":"1994","journal-title":"Arterioscler Thromb."},{"key":"B74","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1194\/jlr.M600361-JLR200","article-title":"Relationship of Igg and Igm autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events","volume":"48","author":"Tsimikas","year":"2007","journal-title":"J Lipid Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/HJR.0b013e32832a05df","article-title":"Low levels of igm antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from Northern Sweden","volume":"16","author":"Gr\u00f6nlund","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1194\/jlr.M015776","article-title":"Relationship of Igg and Igm autoantibodies and immune complexes to oxidized Ldl with markers of oxidation and inflammation and cardiovascular events: results from the epic-norfolk study","volume":"52","author":"Ravandi","year":"2011","journal-title":"J Lipid Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1161\/01.CIR.0000092891.55157.A7","article-title":"Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis","volume":"108","author":"Karvonen","year":"2003","journal-title":"Circulation."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.jacc.2017.04.010","article-title":"Lox-1 in atherosclerosis and myocardial ischemia: biology, genetics, and modulation","volume":"69","author":"Pothineni","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e0229184","DOI":"10.1371\/journal.pone.0229184","article-title":"Lox-1: a potential driver of cardiovascular risk in sle patients","volume":"15","author":"Sagar","year":"2020","journal-title":"PLoS ONE."},{"key":"B80","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3109\/14397595.2015.1128871","article-title":"Plasma slox-1 is a potent biomarker of clinical remission and disease activity in patients with seropositive Ra","volume":"26","author":"Ishikawa","year":"2016","journal-title":"Mod Rheumatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the framingham study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"975640","DOI":"10.3389\/fcvm.2022.975640","article-title":"Linc00452 overexpression reverses oxldl-induced injury of human umbilical vein endothelial cells (Huvecs) via regulating Mir-194-5p\/Igf1r axis","volume":"9","author":"Yuan","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apha.12973","article-title":"Microrna-214-3p: a link between autophagy and endothelial cell dysfunction in atherosclerosis","volume":"222","author":"Wang","year":"2018","journal-title":"Acta Physiol (Oxf)."},{"key":"B84","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2217\/bmm.16.4","article-title":"Association between Lp (a) and atherosclerosis in menopausal women without metabolic syndrome","volume":"10","author":"Gentile","year":"2016","journal-title":"Biomark Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/01.ATV.0000154144.73236.f4","article-title":"Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Qu\u00e9bec cardiovascular study","volume":"25","author":"St-Pierre","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.CIR.95.1.69","article-title":"Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the qu\u00e9bec cardiovascular study","volume":"95","author":"Lamarche","year":"1997","journal-title":"Circulation."},{"key":"B87","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/jama.1996.03540110029028","article-title":"Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women","volume":"276","author":"Gardner","year":"1996","journal-title":"Jama."},{"key":"B88","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jama.1996.03540110036029","article-title":"A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction","volume":"276","author":"Stampfer","year":"1996","journal-title":"JAMA."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s10067-016-3344-4","article-title":"Association between small dense ldl and sub-clinical atherosclerosis in patients with psoriatic arthritis","volume":"35","author":"Gentile","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jacbts.2021.10.017","article-title":"Chantem\u00e8le EJ. HIV, combination antiretroviral therapy, and vascular diseases in men and women","volume":"7","author":"Kovacs","year":"2022","journal-title":"JACC."},{"key":"B91","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2022.06.001","article-title":"People living with human immunodeficiency virus: cardiovascular risk screening for an early and effective risk management","volume":"353","author":"Fogacci","year":"2022","journal-title":"Atherosclerosis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/ATVBAHA.117.309137","article-title":"Lipoprotein(a) and HIV: allele-specific apolipoprotein(a) levels predict carotid intima-media thickness in HIV-infected young women in the women's interagency HIV study","volume":"37","author":"Enkhmaa","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/OARRR.S206931","article-title":"Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis","volume":"11","author":"Peluso","year":"2019","journal-title":"Open Access Rheumatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3899\/jrheum.190261","article-title":"Predictive utility of cardiovascular risk prediction algorithms in inflammatory rheumatic diseases: a systematic review","volume":"47","author":"Colaco","year":"2020","journal-title":"J Rheumatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/bmj.316.7125.140","article-title":"Spurious precision? Meta-analysis of observational studies","volume":"316","author":"Egger","year":"1998","journal-title":"BMJ."},{"key":"B96","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/jech.2005.035253","article-title":"Systematic reviews of meta-analyses: applications and limitations","volume":"60","author":"Delgado-Rodr\u00edguez","year":"2006","journal-title":"J Epidemiol Community Health."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1023651\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:50:39Z","timestamp":1673848239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1023651\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":96,"alternative-id":["10.3389\/fcvm.2022.1023651"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1023651","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"article-number":"1023651"}}